Skip to main content
Livermore
Livermore
ZHEN

Green Alpha Advisors, LLC

SEC CIK
0001439207
Latest filing
Aug 11, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Green Alpha Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q2 2026)
55,804
Value
$3.04M
% of portfolio
2.0%
Quarters held
22
Since Q1 2021
Holdings of CRSP by Green Alpha Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202655,804$3.04M2.0%−1,218−2.1%ReducedHolders
Q1 202657,022$2.71M2.7%+1,285+2.3%AddedHolders
Q4 202555,737$2.92M2.7%+725+1.3%AddedHolders
Q3 202555,012$3.57M3.4%−3,451−5.9%ReducedHolders
Q2 202558,463$2.84M2.7%+1,102+1.9%AddedHolders
Q1 202557,361$1.95M2.1%+32,732+132.9%AddedHolders
Q4 202424,629$969.4K0.8%+5,471+28.6%AddedHolders
Q3 202419,158$900.0K0.7%−479−2.4%ReducedHolders
Q2 202419,637$1.06M0.9%−7,319−27.2%ReducedHolders
Q1 202426,956$1.84M1.3%+2,406+9.8%AddedHolders
Q4 202324,550$1.54M1.1%−10,330−29.6%ReducedHolders
Q3 202334,880$1.58M1.2%+507+1.5%AddedHolders
Q2 202334,373$1.93M1.3%+1,790+5.5%AddedHolders
Q1 202332,583$1.47M1.0%+1,937+6.3%AddedHolders
Q4 202230,646$1.25M1.0%+3,180+11.6%AddedHolders
Q3 202227,466$1.79M1.5%−200,820−88.0%ReducedHolders
Q2 2022228,286$13.9M3.2%+202,753+794.1%AddedHolders
Q1 202225,533$1.60M1.1%+8,374+48.8%AddedHolders
Q4 202117,159$1.30M0.9%+2,237+15.0%AddedHolders
Q3 202114,922$1.67M1.2%+2,214+17.4%AddedHolders
Q2 202112,708$2.06M1.4%+5,914+87.0%AddedHolders
Q1 20216,794$828.0K0.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.